Catalyst
Monitor results from the trial to see if the OD-C approach proves effective, which could lead to new standards in mental health care for cancer patients.
Humanexa recommends Monitor.
Date
July 15, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.